Contract Services Contract Research

WuXi Biologics attains leadership status in 2023 CDP Climate Change evaluation

  CDP runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impact. In 2023, more than...

 March 06, 2024 | News

Medidata and Sanofi Boost Trial Efficiency with Expanded Patient-Centric Collaboration

 Medidata, a Dassault Systèmes subsidiary and a leading provider of clinical trial solutions for the life sciences industry, today announced a ...

 February 29, 2024 | News

RSSL Launches Innovation Hub for Biotech Support with Labs and Services

  RSSL’s Innovation Hub will be a supportive ecosystem for early-stage biotech companies, providing a wide range of tailored services to help t...

 February 22, 2024 | News

WuXi Biologics Achieves Milestone with 16,000L Manufacturing Run in Ireland

First manufacturing run successful for MFG7 facility at the Ireland site Largest manufacturing scale to date achieved by combining four 4,000-liter sing...

 February 01, 2024 | News

WuXi XDC Partners with Multitude and HySlink for Accelerated ADC Discovery and Development

WuXi XDC will provide a fully integrated, one-stop bioconjugate platform and end-to-end CRDMO services. As WuXi XDC's strategic partner, Multitude Therapeu...

 January 31, 2024 | News

Nanoform Achieves Key Milestone in Clinical Trials for Enhanced Enzalutamide

These were from a relative bioavailability study of nanocrystalline-enabled enzalutamide (nanoenzalutamide) tablet formulation, an alternative to the amorp...

 January 29, 2024 | News

Catalent Pledges to Slash Greenhouse Gas Emissions by 2030

Catalent, Inc.  the leader in enabling the development and supply of better treatments for patients worldwide, announced its targets to reduce greenho...

 January 26, 2024 | News

Charles River Streamlines AAV Vector Manufacturing with Rep/Cap Plasmids Launch

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf Rep/Cap plasmid offering, designed to streamline...

 January 17, 2024 | News

ClinChoice Strengthens Global Presence with Acquisition of CSI, Ventures into Southeast Asia

Through this strategic acquisition, ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout&nbs...

 January 12, 2024 | News

WuXi XDC Partners with IntoCell to Boost ADC Discovery and Development

Under the agreement, IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate (OHPASTM) Linker and novel...

 January 03, 2024 | News

Australian Neuren Phase 2 Trial Reveals Significant Improvements in Phelan-McDermid Syndrome

Highlights:  Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures   Improvements were con...

 December 19, 2023 | News

Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million...

 November 30, 2023 | News

Is Asia ready to be the next global biotech hub?

  As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...

 November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva

WuXi XDC Successfully Listed on the Main Board of Hong Kong Stock Exchange

WuXi XDC issued a total of 178,446,000 shares under the global offering at an offer price of HK$20.60 per share (being the high-end of the indica...

 November 20, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close